Carbaspirin calcium CAS NO. :5749-67-7

Original
price: Negotiable
minimum:
Total supply:
Delivery term: The date of payment from buyers deliver within days
seat: Beijing
Validity to: Long-term effective
Last update: 2017-12-20 19:15
Browse the number: 153
inquiry
Company Profile
 
 
Product details
Name: Carbaspirin calcium
English alias :carbasalate calcium; calcium 2 - (acetyloxy) benzoate - urea (1:2:1) [1]
CAS NO. :5749-67-7
EINECS :227-273-0
Formula :CA (C9H7O4) 2CH4N2O
Molecular weight of 458.44
Pharmacological effects of white crystalline powder, slightly bitter taste, easily soluble in water. Acetyl salicylic acid, calcium and urea complex metabolic characteristics and the same pharmacological effects of aspirin, has antipyretic, analgesic, anti-inflammatory and inhibit platelet aggregation, preventing thrombosis caused by various reasons. Rapid oral absorption, rapid onset, bioavailability, metabolized by the liver, renal excretion.
Indications are mainly used for colds, fever, headache, toothache, neuralgia, menstrual pain, rheumatism and rheumatoid arthritis, prevention of transient ischemic attack, myocardial infarction, thrombosis or other surgery.

How to proceed your orders:
1. Please let me know the items you are favorable, assay,quantities, and the destination country.
2. You confirm all details, and offer us purchasing order;
3. We send the detail information contain the quality and price of our product and offer the suitable shipping method for reference.
4. You confirm the order and pay money 100% in advance and send us the detailed contacting information, including contacting person/company, address, mobile number,ZIP code and your special requirements.
5. We arrange the shipment according to your requirements, and tracking code will be offered after claiming the payment within 24h, then you can track your parcel at any moment.
6. We offer after-sales service after you receive parcel
Total0bar [View All]  Related Comments
 
more»Other products

[ Products search ] [ favorites ] [ Tell friends ] [ Print ] [ Close ]